APA

Kateete D. P., Kamulegeya R., Kigozi E., Katabazi F. A., Lukoye D., Sebit S. I., Abdi H., Arube P., Kasule G. W., Musisi K., Dlamini M. G., Khumalo D. & Joloba M. L. (20200108). Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016). : BMC pulmonary medicine.

Chicago

Kateete David Patrick, Kamulegeya Rogers, Kigozi Edgar, Katabazi Fred Ashaba, Lukoye Deus, Sebit Sindani Ireneaus, Abdi Hergeye, Arube Peter, Kasule George William, Musisi Kenneth, Dlamini Myalo Glen, Khumalo Derrick and Joloba Moses L. 20200108. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016). : BMC pulmonary medicine.

Harvard

Kateete D. P., Kamulegeya R., Kigozi E., Katabazi F. A., Lukoye D., Sebit S. I., Abdi H., Arube P., Kasule G. W., Musisi K., Dlamini M. G., Khumalo D. and Joloba M. L. (20200108). Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016). : BMC pulmonary medicine.

MLA

Kateete David Patrick, Kamulegeya Rogers, Kigozi Edgar, Katabazi Fred Ashaba, Lukoye Deus, Sebit Sindani Ireneaus, Abdi Hergeye, Arube Peter, Kasule George William, Musisi Kenneth, Dlamini Myalo Glen, Khumalo Derrick and Joloba Moses L. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016). : BMC pulmonary medicine. 20200108.